Business Courses
Epigenetics, microRNA, and Long Non-Coding RNAs: Research Market and Biomarker OpportunityThis Business Course is being held in Frankfurt, Germany on the 02 September 2013 at 13:00-16:00
|
|
Enal Razvi
Managing Director,
Select Biosciences Inc |
|
This Business Course Presents an Up-to-Date Analysis of the Technology and Business Trends in the Epigenetics, microRNA, and Long Non-coding RNA (lncRNA) Fields for Research and Biomarker Development.
Topics Presented in this Business Course:
- Epigenetics Research Market Segmentation, Market Size, Quantitative Market Forecast, and Growth Rates
- Quantitative Penetration of Technologies for Study of Epigenetic Modifications
- Study of Epigenetic Enzymes: Market Breakout
- Disease Classes Studied Today where Epigenetic Modifications are Being Mapped
- Epigenetic Biomarkers Characterized Currently, Disease Areas Addressed
- MicroRNA Research Market Segmentation, Size, Quantitative Forecast, and Growth
- MicroRNA Research Market Characteristics: End-User Characterization, Quantitative Penetration of Technologies and Vendors
- Disease Classes wherein MicroRNA Research is Clustered
- Analysis of the lncRNA Marketplace
- Review of the Literature
- Potential lncRNAs as Biomarkers
All Course Delegates Receive a CD with Electronic Copies of Materials Presented in PowerPoint and PDF Format with Full Commercial Rights to Use Materials for Business Plans, R&D, and Corporate Presentations.
Who Should Attend:
- Academic Researchers Seeking to Commercialize Technologies, Biomarkers
- University Licensing and Technology Transfer Officials
- Business Development Officers
- Biotechnology and Pharmaceutical Company Researchers Involved with Novel Biomarker Development
For More Details of the Content Presented in this Business Course, Please e-mail: enal@selectbio.us
|
